Prosight Management »

Abivax SA F shares owned by Prosight Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Prosight Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.3M 17k 134.86

More positions owned by Prosight Management

Procept Biorobotics Corp (PRCT)
Galapagos Nv Spon Adr (GLPG)
Janux Therapeutics (JANX)
Adc Therapeutics Sa SHS (ADCT)
Kura Oncology (KURA)
Meiragtx Holdings (MGTX)
Nektar Therapeutics Com New (NKTR)
Veeva Sys Cl A Com (VEEV)
Icon SHS (ICLR)
Boston Scientific Corporation (BSX)
Concentra Group Holdings Par Common Stock (CON)
Phreesia (PHR)
Amicus Therapeutics (FOLD)
Select Medical Holdings Corporation (SEM)
Syndax Pharmaceuticals (SNDX)

View all positions for Prosight Management

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Vestal Point Capital
Susquehanna International
Caligan Partners
FMR
Paradigm Biocapital Advisors
Cormorant Asset Management
ADAR1 Capital Management
Barclays
Millennium Management
Westfield Capital Management Company
Adage Capital Partners GP

View all funds holding Abivax SA F